PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18605443-2 2008 RESULTS: The effect of ectogenic bFGF on proliferation of ACC-2 was observed by MTT assay. monooxyethylene trimethylolpropane tristearate 80-83 fibroblast growth factor 2 Homo sapiens 33-37 22553686-3 2011 RESULTS: At 1, 3 and 5 days after bFGF was added to cat corneal endothelial cells, the result of MTT in 490nm showed significant difference than that in control group, and the difference was most significant in 10ng/mL group. monooxyethylene trimethylolpropane tristearate 97-100 fibroblast growth factor 2 Homo sapiens 34-38 20566037-7 2011 The viability of released FGF2 was evaluated by MTT and cell adhesion tests. monooxyethylene trimethylolpropane tristearate 48-51 fibroblast growth factor 2 Homo sapiens 26-30 17941024-8 2008 The incubation of cell cultures with rh-bFGF released during the first hour led to a significant increase of cell number and of extinction in the MTT assay, whereas this increase was not observed after incubation with rh-bFGF released after 24 h. The in vitro measured biological activity of released growth factors from the surface of synthetic implants is time-depending. monooxyethylene trimethylolpropane tristearate 146-149 fibroblast growth factor 2 Homo sapiens 40-44 18481005-4 2008 MTT demonstrated ACC-2 cell proliferation was substantially enhanced by bFGF, immuno-precipitation displayed ERK activity was up-regulated by bFGF, and immuno-imprinting also showed p-ERK(1/2), cyclin D1 expression was greatly enhanced and p21(waf/cip1) expression was inhibited by bFGF. monooxyethylene trimethylolpropane tristearate 0-3 fibroblast growth factor 2 Homo sapiens 72-76 17219998-5 2006 In the presence of 1 microg/L of bFGF in low serum (0.1% FCS), the pAP transfected cells showed a reduced proliferation rate (MTT assay) while the wild type cells and ph beta Apr-neol transfected cells grew rapidly. monooxyethylene trimethylolpropane tristearate 126-129 fibroblast growth factor 2 Homo sapiens 33-37 17962719-5 2008 Additionally, SHP-2 knock-down abrogated fibroblast growth factor 2 (FGF-2)-dependent endothelial proliferation measured by MTT reduction (p < 0.01; n = 12). monooxyethylene trimethylolpropane tristearate 124-127 fibroblast growth factor 2 Homo sapiens 41-67 17962719-5 2008 Additionally, SHP-2 knock-down abrogated fibroblast growth factor 2 (FGF-2)-dependent endothelial proliferation measured by MTT reduction (p < 0.01; n = 12). monooxyethylene trimethylolpropane tristearate 124-127 fibroblast growth factor 2 Homo sapiens 69-74 14613644-5 2003 MTT assay was used to determine the influence of aFGF and bFGF on the proliferation of ovarian cancer cell. monooxyethylene trimethylolpropane tristearate 0-3 fibroblast growth factor 2 Homo sapiens 58-62 16797368-4 2006 Better neuron growth was observed using the tetrazolium assay (MTT) in the group when basic fibroblast growth factor (bFGF) was coated on the gelatin polymer scaffold. monooxyethylene trimethylolpropane tristearate 63-66 fibroblast growth factor 2 Homo sapiens 86-116 16797368-4 2006 Better neuron growth was observed using the tetrazolium assay (MTT) in the group when basic fibroblast growth factor (bFGF) was coated on the gelatin polymer scaffold. monooxyethylene trimethylolpropane tristearate 63-66 fibroblast growth factor 2 Homo sapiens 118-122 15975645-2 2005 METHODS: Human umbilical endothelial cells were treated with angiostatin or thalidomide and bFGF-induced proliferation was assessed with the MTT assay. monooxyethylene trimethylolpropane tristearate 141-144 fibroblast growth factor 2 Homo sapiens 92-96 15562643-9 2004 RESULTS: Both IGF-II and bFGF upregulated the mtt values (P < 0.05), but ICF-II downregulated the opg/mtt values (P < 0.05), whereas bFGF had no significant effect on opg/mtt values (P > 0.05). monooxyethylene trimethylolpropane tristearate 46-49 fibroblast growth factor 2 Homo sapiens 25-29 27502406-7 2017 The release and performance of bFGF were revealed via human umbilical vein endothelial cell (HUVEC) proliferation using microscopy imaging and MTT assay. monooxyethylene trimethylolpropane tristearate 143-146 fibroblast growth factor 2 Homo sapiens 31-35 1310324-2 1992 Addition of exogenous bFGF to the chemically defined media of five characterized human colon tumor cell lines, cultured in the absence of epidermal growth factor (EGF), resulted in stimulation of growth from 24% to 146% in four of five cell lines, as measured by a colorimetric MTT assay. monooxyethylene trimethylolpropane tristearate 278-281 fibroblast growth factor 2 Homo sapiens 22-26 26846721-10 2016 As bFGF could promote migration and proliferation of endothelial cells, scratch wound healing and transwell migration assays were performed as well as MTT assays and cell cycle analysis. monooxyethylene trimethylolpropane tristearate 151-154 fibroblast growth factor 2 Homo sapiens 3-7 26436096-4 2015 An MTT assay demonstrated that FGF-2 coated BCP had good biocompatibility, regardless of the concentration of FGF-2, after 24 or 48 h of incubation. monooxyethylene trimethylolpropane tristearate 3-6 fibroblast growth factor 2 Homo sapiens 31-36 26032256-6 2015 The role of MEF2 in bFGF-induced activation of PAI-1 promoter activity via ERK5 was measured using a biotin-labeled DNA pull-down assay, and the effects of ERK5 on the mitogenic effects of bFGF were assessed using a MTT assay. monooxyethylene trimethylolpropane tristearate 216-219 fibroblast growth factor 2 Homo sapiens 20-24